Introduction Marchigian Sardinian alcohol-preferring (msP) rats exhibit innate preference for alcohol along with anxious phenotype. In these animals, two single-nucleotide polymorphisms in position −1,836 and −2,097 from the first start codon of the CRF1-R transcript have been found. Materials and Methods Here, we examined whether these point mutations account for the heightened anxiety-like behavior and stress responsiveness of msP rats. We rederived the msP rats to obtain two distinct lines carrying the wild-type (GG) and point mutations (AA), respectively. Results CRF1-R gene expression analysis revealed significant dysregulation of the system in the extended amygdala of AA rats. At the behavioral level, using the elevated plus maze, we found that both AA and GG lines had higher basal anxiety compared to Wistar rats. In the defensive burying test, AA rats showed decreased burying behavior compared to the GG and the unselected Wistar lines. Freezing/immobility did not differ among AA and GG but was higher than that of Wistars. The selective CRF1-R antagonist antalarmin (0, 10, and 20 mg/kg) reduced burying behavior in Wistar animals. However, antalarmin (10 mg/kg) tended to increase rather than reducing this behavior when tested in the msP lines, an effect that appeared more marked in the GG as compared to the AA line. Conclusion The present data suggest that rats with msP genetic background are more anxious and show different sensitivity to stress and CRF1-R blockade than Wistars. The point mutations occurring in the CRF1-R gene do not seem to influence basal anxiety while they appear to affect active responses to stress.
Introduction
Dysregulation of the brain corticotropin-releasing factor (CRF) system appears to be one of the major elements common to depression, anxiety, and alcohol addiction (Markou et al. 1998; Muller and Wurst 2004; Nemeroff and Vale 2005) . CRF is a 41-amino acid peptide that integrates many of the endocrine, behavioral, and autonomic responses to stress (Sarnyai et al. 2001; Vale et al. 1981) . Its arousing and anxiogenic-like properties have been attributed to an enhanced CRF1 receptor (CRF1-R) activation at extrahypothalamic sites (Heinrichs et al. 1997; Muller and Wurst 2004; Skutella et al. 1998; Zorrilla and Koob 2004) whereas there is no consistency in reports on the role of CRF2-Rs in anxiety (Zhao et al. 2007 ). Preclinical studies using conventional and conditional knockout strategies showed decreased anxiety-like behavior in CRF1-R-deficient mice, an effect which was independent of hypothalamicpituitary-adrenocortical system function (Muller et al. 2003 ; Andrea Cippitelli and Lydia O. Ayanwuyi contributed equally to the work. Smith et al. 1998; Timpl et al. 1998) . In agreement with this, pharmacological blockade at CRF1-R produced anxiolytic-like effects in animal models of anxiety including reduced acoustic startle responses (Schulz et al. 1996) , conditioned fear (Hikichi et al. 2000) , and defensive burying (DB) behavior (Richardson et al. 2008; Zhao et al. 2007) .
Increased CRF-like immunoreactivity in the extended amygdala during alcohol withdrawal (Merlo Pich et al. 1995; Olive et al. 2002; Roberto et al. 2010; Zorrilla et al. 2001 ) and long-term upregulation of CRF1-Rs following alcohol dependence induction have also been documented (Sommer et al. 2008 ). In addition, hyperactivation of the CRF1-R system has been linked to excessive alcohol drinking and vulnerability to relapse. For instance, it has been documented that selective CRF1-R antagonists are highly efficacious in reducing alcohol self-administration and stressinduced relapse to alcohol seeking in post-dependent rats (Ciccocioppo et al. 2009; Funk et al. 2006; Gehlert et al. 2007 ; Hansson et al. 2006) . These agents also attenuated alcohol "hangover"-and withdrawal-induced anxiety-like behavior in rats (Gehlert et al. 2007; Overstreet et al. 2004 ). Altogether, these findings corroborate the notion that a prolonged history of alcohol exposure leads to enhanced CRF/CRF1-R system activity that, in turn, sustains uncontrolled alcohol consumption motivated by the attempt to relief of negative emotional state such as anxiety and depression (Breese et al. 2011; Heilig and Koob 2007; Koob 2010) .
Genetically selected Marchigian Sardinian alcoholpreferring (msP) rats have been proposed as a phenocopy of animals in a post-dependent state (Ciccocioppo 2013; Ciccocioppo et al. 2006) . They have an innate high preference for alcohol, show excessive alcohol drinking [6-8 g/kg body weight per day ], are highly sensitive to stress and stress-induced alcohol seeking (Ciccocioppo 2013; Ciccocioppo et al. 2006) , have depressive-like symptoms that recover following alcohol consumption (Ciccocioppo et al. 1999) , and demonstrate an anxious-like phenotype (Hansson et al. 2006) . In previous studies, we demonstrated that msP rats have an innate hyperfunction of the CRF system that is associated with the occurrence of two single-nucleotide polymorphisms (SNPs) in the promoter region (position −1,836 and −2,097) of the gene encoding the CRF1-R (Gehlert et al. 2007; Hansson et al. 2006 Hansson et al. , 2007 . This genetic variation might have parallels in adolescent drinkers and adult alcohol-dependent subjects where similar mutations were found to be associated with patterns of excessive alcohol consumption (Schmid et al. 2010; Treutlein et al. 2006) .
Starting from the original msP line, we rederived two distinct lines, one carrying the two point mutations (AA) and the other being the wild-type line (GG). We have recently shown that the two observed mutations at the CRF1-R locus do not seem to play a major role in the expression of the msP excessive drinking phenotype, while they appear to be associated with decreased threshold for stress-induced reinstatement to alcohol seeking and an enhanced sensitivity to alcohol drinking inhibition by CRF1-R antagonism (Ayanwuyi et al. 2013) . To follow up these initial observations, here, we examined whether these mutations are responsible for the high sensitivity to stress and the heightened anxiety-like behavior of msP rats. Specifically, we first studied CRF1-R gene expression in various brain regions known to play a relevant role in stress, anxiety, and alcohol abuse. Then, we investigated the phenotypic characteristics of the AA and the GG lines in preclinical models of human anxiety and fear comparing their behavior with that of unselected Wistar rats. Lastly, we evaluated their response to CRF1-R inhibition following administration of the selective antagonist, antalarmin.
Material and methods

Animals
Subjects were adult males from two distinct sublines derived from the original msP line (65th generation). Animals were bred at the animal facility of the University of Camerino, Italy. Breeding started following genetic screening of the promoter region encoding for CRF1-Rs as previously described (Ayanwuyi et al. 2013 ). In brief, sequence variation AA versus GG in position −1,836 and −2,097, respectively, from the first start codon of the CRF1-R transcript, distinguished the two msP lines. Eighty msP rats were sequenced using TaqMan PCR analysis of tail DNA to identify animals carrying (AA) or not carrying (GG) both variants. The homozygous male and female AA and GG were then bred to obtain rederived lines selectively carrying the AA and the GG types. They were bred for two more generations, and then, animals from the third and fourth generations were used for experiments. Male Wistar rats (Charles River, Calco, Italy) were employed for comparisons between msP and heterogeneous rats because msP rats were originally selected for their high alcohol preference starting from a stock of heterogeneous Wistar animals. All rats (bw, 300-400 g at the time of the experiments) were housed in groups of four or five on a reverse 12-h light-dark cycle (lights off at 08:30 AM) at a constant temperature of 20±2°C and relative humidity of 45-55 %, with free access to tap water and food pellets (4RF18, Mucedola, Settimo Milanese, Italy). Animals were handled three times before each experiment and used only once. All procedures followed the EU Directive for Care and Use of Laboratory Animals and were approved by the Ethical Committee of the University of Camerino, Italy.
Drugs
The selective CRF1-R antagonist antalarmin (N-butyl-N-ethyl-[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl (Webster et al. 1996) was obtained from the National Institute on Alcohol Abuse and Alcoholism (NIAAA/NIH). Antalarmin was suspended in a vehicle composed of 10 % Tween 80 and distilled water and was administered intraperitoneally (i.p.) in a 1 ml/kg volume injection. Doses and time of injection were as described elsewhere (Cippitelli et al. 2012) . Physiological saline was injected three times prior to drug testing for habituation to the experimental procedures.
EPM test
To measure anxiety-like responses, the elevated plus maze (EPM) test was used as previously described (Cippitelli et al. 2011b ). The apparatus consisted of two wooden open arms (50×10 cm) and two enclosed arms (50×10×40 cm) which were arranged so that the similar arms were opposite each other and situated 60 cm above the floor. The 5-min procedure started by placing each animal in the center of the maze (10× 10 cm) facing a closed arm. The test was conducted in a quiet room illuminated by dim red light. Six groups of animals were used. Three of them (N=24, 8 GG, 8 AA msPs, and 8 Wistar rats) were subjected to the test procedure under basal conditions, whereas the other three groups (N=22, 6-8 per group) were previously exposed to 60-min restraint stress in cylindrical Plexiglass tubes right before the rats were allowed to explore the maze. The percentage of time spent exploring the open arms and the percentage of open arm entries were used as measures of anxiety-like behavior, whereas the number of entries into the closed arms was used as an indicator of general motor activity (Pellow et al. 1985 ). An entry into an arm was defined as the animal placing all four paws over the line marking that area. The apparatus was cleaned with tap water between each rat performance.
Fear conditioning test
Fear conditioning was assessed as described (Bast et al. 2001; Hansson et al. 2006 ) by using operant conditioning chambers (Med Associates Inc., Georgia, VT). On the first day (conditioning phase), rats were placed individually in a chamber which was programmed to deliver five unsignaled 1-s footshocks (1.0 mA) through the grid floor at 5-min intervals for a 30-min period. The time of freezing was recorded at 5-min intervals. On the following day (expression phase), rats were placed individually in the same experimental context with the exception that the foot-shock was no longer released. The time of freezing was recorded at 1-min intervals for an 8-min period. Data are reported as total time spent freezing during six consecutive 5-min blocks of the conditioning phase and 8-min reexposure to the context previously associated with footshock (expression). N=26 rats (eight Wistar, nine GG, and nine AA msP rats) were employed in this experiment.
Shock-probe DB test
The shock-probe DB test (Pinel and Treit 1978) was carried out as previously described (Cippitelli et al. 2011a ). The DB apparatus was a modified home cage with 5-cm high wood chip bedding material evenly distributed throughout the cage. One side of the cage contained a round hole of diameter 0.75 cm through which a probe delivering 1.5-mA electric shock was inserted. As for EPM, the DB test was conducted in a quiet room illuminated by dim red light. Rats were kept in the quiet test room for at least 3 h on the day before the experiment for the purpose of acclimatization. On the test day, the shock-probe was connected to a shocker instrument (Med associates, Inc.) and remained turned on throughout the test. Upon the first contact with the shock-probe, the burying behavior of the rat was recorded for 15 min. Contacts with the probe resulted in the rat piling bedding material with treadinglike movements of the forepaws and shoveling movements of the head, often directed toward the shock-probe. The latency to start burying and the duration of burying were dependent variables that served as measures of anxiety-like/fear-like behaviors. The chip bedding material was changed before each rat performance. Three experiments were carried out by using this paradigm. DB behavior was first examined in the two msP rat lines (N=8 GG and N=8 AA) and compared to that of Wistar rats (N=8) and Wistar rats previously exposed to 60-min restraint stress (W/restraint, N=8). In a second experiment, the effect of the selective CRF1-R antagonist antalarmin was tested. Antalarmin was administered to Wistar (N=23, 7-8 per treatment dose), GG msP (N=47, 14-17 per dose), and AA msP (N=40, 13-14 per dose) rats at doses of 0, 10, and 20 mg/kg, 30 min before the onset of the DB test. Finally, antalarmin was tested in additional Wistar rats (N=29) previously exposed to 60-min restraint stress. The CRF1-R antagonist (0, 10, and 20 mg/kg) was administered 30 min prior to restraint, and behavioral performance in the DB test was compared with that of Wistars receiving antalarmin 0 mg/kg not exposed to stress.
Brain collection, reverse transcription, and qPCR Brains (N=24) from Wistar (N=8), GG msP (N=8), and AA msP (N=8) were collected and snap-frozen with isopentane for measurements of CRF1-R messenger RNA (mRNA) levels. The brains were sliced on a cryostat, and bilateral punches (300-μm thickness, 2-mm diameter) were collected from the medial region of the prefrontal cortex (mPFC), septum, nucleus accumbens (NAcc), bed nucleus of the stria terminalis (BNST), amygdala (Amy), paraventricular nucleus of the hypothalamus (PVN), and median raphe nucleus (MRN). Reverse transcription and quantitative real-time polymerase chain reaction (qPCR) were conducted as described elsewhere (Barbier et al. 2013) . In brief, RNA was extracted and purified from brain tissue using the PureLink™ RNA Mini Kit (Ambion, Austin, TX) following the manufacturer's instructions. Complementary DNA (cDNA) was reverse transcribed from total RNA using the Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA). Gene expression levels were determined by qPCR using a TaqMan Universal PCR Master Mix (Applied Biosystems Inc., Foster City, CA). cDNA concentrations of the CRF1-R transcript (CRF1-R) were calculated according to the relative quantification (ΔΔCt) method, corrected for differences in PCR efficiency, normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh). Primers used were as follows: TaqMan qPCR utilized commercially available CR F1-R (Rn00578611_m1) and Gapdh (Rn99999916_s1) primer/ probe sets, (Applied Biosystems Inc., Foster City, CA), with PCR conditions according to the manufacturer's protocol. Data was reported as percentage of control (Wistar group).
Statistical analysis EPM data were analyzed by means of a two-way analysis of variance (ANOVA) where rat "line" and "restraint" were between-subject factors. Analysis of DB and fear conditioning data was carried out by means of one-way ANOVA with the rat line as between-subject factor. To evaluate CRF1-R mRNA expression levels, one-way ANOVA was also used to analyze the brain regions independently. The effect of antalarmin was analyzed by means of a two-way ANOVA with "rat line" and "drug treatment" as the between-subject factors. The effect of antalarmin on burying behavior of Wistar rats previously exposed to restraint was analyzed separately using one-way ANOVA with "group" as a between-subject factor. Accepted p level was p<0.05 for behavioral data and p<0.01 for gene expression data. When appropriate, analyses of behavioral data were followed up by Fisher's least significant difference (LSD) post hoc tests while qPCR data were followed by Tukey-Kramer post hoc tests.
Results
CRF1-R gene expression levels in AA, GG, and Wistar rats
Expression of the CRF1-R gene was evaluated on a network of structures densely populated in CRF1-Rs (Contarino and Gold 2002) or previously reported to be associated with anxiety-and fear-like behaviors as well as pathophysiological response to stress (De Boer and Koolhaas 2003) . MsP lines showed different expression in CRF1-R mRNA levels in the Amy [F (2,20) Basal anxiety levels and stress-induced anxiety in the EPM test EPM results indicated that under basal conditions, both GG and AA msP lines showed increased anxiety-like behavior compared to unselected Wistar rats. However, no significant differences between the two alcohol-preferring lines were observed. Further, EPM data showed that exposure to restraint stress produced heightened anxiety levels in all three rat lines Fig. 1b) . However, the observed difference in these anxiety-related variables was associated to a different number of entries into the closed arms since ANOVA showed overall significant difference for the main effect of line [F (2,40) Overall ANOVA comparing Wistar, GG, AA msPs, and Wistar rats previously exposed to 60-min restraint stress revealed a significant difference in the total time spent burying [F (3,28) =7.4, p < 0.001]. Pairwise comparisons indicated higher burying time in Wistar rats compared to GG (p<0.05) and AA (p<0.001). Noteworthy, the burying time of AA was also lower (p<0.05) compared to that of GG rats. Wistar rats subjected to restraint showed decreased burying, compared to non-restrained Wistars (p<0.01), suggesting that exposure to stress decreases this stress-coping behavior (Fig. 3a) . When the latency to start burying was evaluated (Fig. 3b) , overall ANOVA showed increased latency to start burying [F (3,28) = 4.9, p<0.01]. Post hoc analysis revealed a significant higher latency to bury in the AA rats compared to GG or non- When the latency to start burying was evaluated (Fig. 4b) DB response in Wistar rats exposed to restraint following antalarmin treatment One-way ANOVA, conducted in unselected Wistar rats exposed to restraint following antalarmin treatment and a group of Wistars receiving the vehicle of antalarmin and not exposed to restraint, revealed changes in the total duration of DB behavior [F (3,25) =8.1, p<0.001]. Post hoc analysis indicated an expected reduction in time of burying of the restrained group non-pretreated with antalarmin as compared to the group not exposed to stress (p<0.01). In a manner similar to the effects of antalarmin observed in the msP lines, group comparisons also indicated that treatment with 10 mg/kg antalarmin prior to restraint significantly increased the burying time (p<0.05) compared to the restrained group receiving antalarmin 0 mg/kg. At the higher dose (20 mg/kg), antalarmin did not appear to evoke significant effects (Fig. 5) .
Latency to initiate burying was also changed [F (3,25) =4.7, p<0.01] with the antalarmin 20 mg/kg group being substantially increased as compared to the other treatment groups.
Mean±SEM latency to start burying for the four groups was 287.4±61.9 (antalarmin vehicle/no restraint), 358.9±141.3 (antalarmin vehicle/restraint), 116.3±18.1 (antalarmin 10/restraint), and 611.4±96.5 s (antalarmin 20/restraint).
Discussion
The gene expression analysis reported here indicated significant CRF1-R over-expression in the amygdala of both AA and GG rats compared to the progenitor Wistar line. Although binding data on brain CRF1-R protein levels in AA and GG rats are not provided here, this elevated CRF1-R expression may reflect increased density of CRF1-R sites in numerous brain regions, including different portions of the amygdala, as we previously demonstrated in the original msP line from which the AA and GG lines were derived (Hansson et al. 2006) . Increased CRF function in the central nucleus of the amygdala (CeA) has been linked to excessive anxiety-like behavior in the EPM (Ciccocioppo et al. 2014; Ji et al. 2007) . In excellent agreement with this evidence, in the EPM test, we found that the AA and GG lines express lower exploratory behavior and spent less time in the open arm of the maze compared to heterogeneous Wistar rats. Closed arm entries were also reduced in AA and GG rats compared to Wistars. This is consistent with previous published data showing that exploratory behavior in msP rats is reduced under condition of novelty (Hansson et al. 2006 ). On the other hand, the two examined polymorphisms at CRF1-R locus did not seem to determine the innate anxiogenic phenotype of our two lines of alcohol-preferring animals. In fact, no differences between AA and GG rats were observed in the EPM test. Previous studies have shown that msP rats from which the AA and the GG were derived are highly sensitive to stress exposure Hansson et al. 2006) . Hence, we decided to expand our EPM study by looking at whether the observed point mutations in the CRF1-R gene would play a role in enhanced anxiety resulting from exposure to a stressful stimulus. The test was therefore replicated in GG, AA, and unselected Wistars previously subjected to 1-h restraint stress. As expected, stress exposure elicited a considerable anxiogenic-like response in Wistar rats that showed levels of anxiety comparable to those seen in the AA and GG lines without restraint. A trend toward increased anxiety-like behavior was also observed in AA and GG rats that showed further decreased time spent in the open arms and entries onto the open arms of the maze. Although the AA line appeared to be more responsive to the restraint stress than the GG line, statistical analysis did not show significant line difference. We argued that possible floor effects may have attenuated the possibility to detect potential differences between the lines. Therefore, to better address this issue, we studied the behavior ** *** # Fig. 5 Effect of the selective CRF1-R antagonist antalarmin (0, 10, and 20 mg/kg, i.p.) in the DB performance of Wistar rats (N=29, 6-8 per group) previously exposed to 60-min restraint stress. Antalarmin or vehicle (0 mg/kg) was administered 30 min prior to restraint that preceded the 15-min DB performance. Vehicle of antalarmin was injected to a rat group not exposed to restraint that served as control. Time of burying values are expressed in mean (±SEM) seconds (sec); **p < 0.01, ***p<0.001, difference from control; #p<0.05, difference from rats exposed to restraint following antalarmin 0 mg/kg treatment. For detailed statistics, see Results section of AA and GG rats in the fear conditioning model which reflects fear-like responses generated by exposure to stressful environmental conditions rather than generalized anxiety disorders. Results showed that both AA and GG lines subjected to contextual fear conditioning showed higher time of freezing (complete absence of somatic motility except for respiratory movements) as compared to Wistar rats during both the acquisition and recall sessions with freezing levels being indistinguishable between the two lines. It is known that neuronal processing in the amygdala is important for classical fear conditioning to contextual as well as explicit conditioned stimuli (Goosens and Maren 2001; LeDoux 2000) , and work carried out using electric shock stress has suggested that the central portion of the amygdala is predominantly involved in the expression of passive behavioral coping (Legradi et al. 2007; Roozendaal et al. 1997) . On the other hand, the basolateral amygdala has been shown to be implicated in the acquisition of fear-related behaviors (Bijlsma et al. 2011) . Hence, although the longer acquisition latency observed in both AA and GG lines compared to the Wistar is an important evidence of spontaneously increased inhibitory/passive response to stress in msP rats, the negative finding in the fear conditioning test (no differences between AA and GG rats) nicely correlates with the over-expression of the CRF1-R gene found in the amygdala of both msP rat lines compared to Wistars and suggests the lack of a functional role for the examined polymorphisms in passive fear response. An important difference in CRF1-R expression was found in BNST, where AA rats showed significantly lower expression levels of the transcript than the Wistar group. The BNST is an important structure implicated in the integration and processing of stress responses, plays a role pathological anxiety (Hammack et al. 2004; Sparta et al. 2013) , and is a critical neuroanatomical substrate for stress-induced reinstatement of drug seeking, where CRF plays a major role (Erb and Stewart 1999; Silberman and Winder 2013) . This suggests that CRF neurotransmission in the BNST is involved in triggering active reactions to stress. Moreover, activation of the CRF system in the BNST seems to contribute to the expression of defensive behavior, and CRF antagonists directly injected into this nucleus attenuate it (Jasnow et al. 2004 ). Finally, it has been reported that administration of a CRF antagonist into the BNST did not attenuate phasic but blocked sustained fear behaviors (Davis et al. 2010) , indicating that this structure may be recruited to regulate forms of anxiety associated to a more long-lasting state of apprehension rather than transient fear. Based on this background, we postulated that the different organization of the CRF system in the BNST of AA rats would influence active stress coping responses in this rat line.
To test this hypothesis, we used the shock-probe DB model originally described by Pinel and Treit (1978) . This model seems to be particularly appropriate to examine whether the observed SNPs in the CRF1-R gene would have functional relevance, as it requires rats to engage in an active behavioral response to stress (to bury an electrified probe) and is highly dependent on the extrahypothalamic CRF system (Basso et al. 1999; De Boer and Koolhaas 2003) . For instance, CRF administration increases DB in rats (Diamant et al. 1992) , and CRF antagonists block this response (Basso et al. 1999; Richardson et al. 2008) . In the DB test, we found that the AA line had the lowest total time of burying in a single 15-min trial as well as the highest latency to start burying followed by the GG line and, then, the unselected Wistar rats. This result is indicative of the fact that the examined polymorphisms in the CRF1-R gene could play a role in regulating active forms of stress avoidance behavior. To some extent, the decreased burying response observed in AA rats, and also partly in the GG line, contradicts the common notion that higher stress sensitivity and increased anxiety positively correlate with enhanced burying response DB test (De Boer and Koolhaas 2003; Korte et al. 1994) . To reconcile this apparent paradox, we subjected Wistar rats to restraint stress prior to the DB, and we found that after this stress manipulation, the burying behavior of Wistar rats was dramatically reduced and similar to that observed in the AA line. These data suggest that when animals are in a state of excessive stress, either innate as in AA and GG rats or evoked following physical restraint, they lose the ability to engage in active reactions to stress. Evidence linking these behavioral responses to over-function of the CRF system also exists. For example, it has been documented that CRF1-R agonist stressin 1 -A elicited burying reactions at low doses but increased freezing at 25-fold higher doses switching the behavior of rats from active to passive (Zhao et al. 2007 ). Another study showed that cortagine, a selective CRF1-R agonist, administered bilaterally into the cerebral ventricles of rodents evoked anxiogenic-like effects in a model of defensive behaviors by dose dependently enhancing passive avoidance and freezing, while burying was decreased (Tovote et al. 2010) .
To prove that DB response was under the control of the CRF1-R system, we administered antalarmin. Interestingly, blockade of CRF1-R resulted in opposite responses. Confirming previously published data in Wistar rats, it reduced the burying behavior (Heinrichs et al. 2002; Richardson et al. 2008) . On the other hand, antalarmin increased the burying response in GG and AA rats at the low dose, an effect that disappeared at higher dosages. This reversal of a previously inhibited burying behavior could be attributed to the ability of antalarmin to contrast the abnormally heightened anxiety/stress state of msP rats, bringing it back to normal levels, thus enabling regain of active stress coping response (i.e., increase in burying behavior). Additional evidence that a low antalarmin dose administered to unselected Wistar animals exposed to acute restraint stress produced a similar DB response than observed in the msP lines strengthens this view. In agreement, a more complete blockade of the CRF1-Rs as that obtained by administering antalarmin at high doses led to a full anxiolytic effect that, in turn, resulted in burying reduction.
At present, it is unclear how to reconcile the hypersensitivity to stress observed in AA and GG rats with reduced expression of CRF1-R transcript in the BNST. It is possible that downregulation of the transcript is part of a compensatory change in CRF1-R expression aimed at balancing the overfunction of the CRF system in the CeA of msP rats (Hansson et al. 2006; Herman et al. 2013) . In this respect, the more pronounced reduction in CRF1-R transcript associated with the polymorphisms found in AA rats may be viewed as an additional compensatory mechanism occurring in this rat line. For instance, it may be argued that the low CRF1-R transcript level in AA rats may reflect changes at neurocircuitry levels (i.e., reduction in the number of CRF1-R-positive neurons in the BNST). Several pieces of evidence, in fact, indicate profound reorganization of this nucleus as a result of exposure to stress. For instance, it has been shown that in the BNST, stress can have a major impact on dendritic/synaptic remodeling (Pego et al. 2008) , blunts neuronal plasticity (Conrad et al. 2011) , and can change GABAergic and glutamergic innervation of the nucleus (Ventura-Silva et al. 2012) . Additional studies will have to be performed to understand the impact of CRF system over-activation and CRF1-R transcript polymorphisms occurring in the AA line on the neuroanatomical and functional organization of the BNST.
In conclusion, two major findings are outlined here. First, we show that two previously identified point mutations at the CRF1-R gene locus do not seem to play a major role in basal anxiety or in passive behavioral responses to stress. However, they appear to contribute to a reduced capacity to actively react to stress. Secondly, these findings may have important pharmacogenetic implications because they support the notion that polymorphisms at CRF1-R locus correlate with stress hypersensitivity and possibly with specific forms of anxiety.
